These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 2756462

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of intervention surgery in stage III-IV epithelial ovarian carcinoma.
    Hoogland H, Blijham G, Bron H, Eekhout A, van Geuns H, Haest J, Huiskes H, Kornman J, de Koning Gans H, Lalisang F.
    Prog Clin Biol Res; 1985; 201():213-5. PubMed ID: 3841592
    [No Abstract] [Full Text] [Related]

  • 4. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T, Adolph A, Krepart GV, Lotocki R, Heywood MS.
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS, Hacker NF, Lagasse LD, Poth T, Resnick B, Nieberg RK.
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [Abstract] [Full Text] [Related]

  • 7. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A, Landoni F, Sartori E, Maggino T, Zola P, Gabriele A, Rossi R, Cosio S, Fanucchi A, Tisi G.
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [Abstract] [Full Text] [Related]

  • 8. [Radical peritonectomy in 37 patients with stage II and III ovarian cancer].
    Capretti PG, Zeppieri MC, Simonetti A, Rosato S, Lovotti D, Battaini A, Capretti G, Agnes Pradelli B.
    Minerva Chir; 2004 Jun; 59(3):233-41. PubMed ID: 15252388
    [Abstract] [Full Text] [Related]

  • 9. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
    Dusenbery KE, Bellairs EE, Potish RA, Twiggs LB, Boente MP.
    Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE.
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [Abstract] [Full Text] [Related]

  • 11. [Secondary cytoreductions in the treatment of ovarian cancers].
    Zylberberg B, Dormont D, Janklewicz S, Daraï E, Madelenat P, Antoine JM.
    Gynecol Obstet Fertil; 2000 Feb; 28(2):127-36. PubMed ID: 10758587
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma.
    Chiara S, Conte PF, Bruzzone M, Falcone A, Sertoli MR, Carnino F, Mossetti C, Iura R, Durando C, Guercio E.
    Chemioterapia; 1987 Oct; 6(5):380-3. PubMed ID: 3427698
    [Abstract] [Full Text] [Related]

  • 13. Stage III-IV epithelial carcinoma of the ovary: is the second-look operation of any value for the patient?
    Atad J, Bornstein J, Steiner M, Weill S, Lurie M, Abramovici H.
    Isr J Med Sci; 1988 Nov; 24(11):660-3. PubMed ID: 3215758
    [Abstract] [Full Text] [Related]

  • 14. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
    Peccatori F, Bonazzi C, Chiari S, Landoni F, Colombo N, Mangioni C.
    Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
    [Abstract] [Full Text] [Related]

  • 15. [Survival in ovarian cancer treated in a gynecological department of a central hospital].
    Dragsted NO, Nørgaard M, Bøsling KB.
    Ugeskr Laeger; 1997 May 12; 159(20):3003-9. PubMed ID: 9190729
    [Abstract] [Full Text] [Related]

  • 16. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG, Gershenson DM, Malpica A, Deavers M.
    Am J Surg Pathol; 2006 Nov 12; 30(11):1367-71. PubMed ID: 17063075
    [Abstract] [Full Text] [Related]

  • 17. Peptichemio in pretreated patients with ovarian cancer.
    Paccagnella A, Tredese F, Salvagno L, Brandes A, Sileni VC, Daniele O, Fornasiero A, Fosser V, Nicoletto O, Maggino T.
    Cancer Treat Rep; 1985 Jan 12; 69(1):17-20. PubMed ID: 3155650
    [Abstract] [Full Text] [Related]

  • 18. Epithelial ovarian tumors of borderline malignancy: long-term follow-up.
    Casey AC, Bell DA, Lage JM, Fuller AF, Nikrui N, Rice LW.
    Gynecol Oncol; 1993 Sep 12; 50(3):316-22. PubMed ID: 8406194
    [Abstract] [Full Text] [Related]

  • 19. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S, EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.
    J Natl Cancer Inst; 2003 Jan 15; 95(2):113-25. PubMed ID: 12529344
    [Abstract] [Full Text] [Related]

  • 20. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT, Calaminus G, Wessalowski R, Pathmanathan R, Harms D, Göbel U.
    Klin Padiatr; 2002 Jan 15; 214(4):173-8. PubMed ID: 12165898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.